SRDX logo

Surmodics (SRDX)

Profile

Full Name

Surmodics, Inc.

Ticker Symbol

SRDX

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

March 4, 1998

Indexes

Not included

Website

http://www.surmodics.com

Employees

389

Key Details

Price

$29.46(+0.20%)

Market cap

$421.16M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$126.08M(-4.91% YoY)

Annual EPS

-$0.82(-645.45% YoY)

PE ratio

-

Next earnings date

May 1, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$29.46
SRDX price is $29.46

30-Day Relative Volume

0.49
SRDX 30-day relative volume is 0.49

Price Performance

Price Most recent change

+0.2%
SRDX price was up +0.2% on Apr 25, 2025

Price YTD change

-25.61%
SRDX price is down -25.61% since January 1st

Price 1-year change

+12.57%
SRDX price is up +12.57% year-on-year

Price 3-year change

-30.07%
SRDX price is down -30.07% over the past 3 years

Price Range

Price All-time high

$82.35
SRDX price is currently -64.23% below its historical high of $82.35

Price 3-year low

$16.00
SRDX price is currently +84.13% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$421.16M
SRDX market capitalization is $421.16 million

Market cap 3-year change

-28.54%
SRDX market capitalization is down -28.54% over the past 3 years

Market cap All-time high

$1.07B
SRDX market capitalization is currently -60.74% below its historical high of $1.07 billion

Market cap sector rank

65.95%
SRDX market capitalization is higher than 65.95% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.25%
SRDX shares outstanding is up +0.25% year-on-year

Shares Outstanding 3-Year Change

+2.19%
SRDX shares outstanding is up +2.19% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.32
SRDX beta is 0.32

200-day SMA

$36.82
SRDX price is currently -19.99% below its 200-day simple moving average

50-day SMA

$30.38
SRDX price is currently -3.04% below its 50-day simple moving average

RSI

51.29
SRDX 14-day relative strength index is 51.29

Volume

0.49
SRDX 30-day relative volume is 0.49

ATR

$1.36
SRDX average true range is $1.36

10-day Historical Volatility

33.42%
SRDX 10-day historical volatility is 33.42%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$126.08M
SRDX annual revenue is $126.08 million

Revenue Analysts estimate

$127.27M
SRDX annual revenue is currently -0.94% lower than the consensus analysts' forecast

Revenue 1-year change

-4.91%
SRDX annual revenue is down -4.91% year-on-year

Revenue Sector rank

58.25%
SRDX annual revenue is higher than 58.25% of companies in Healthcare sector

EPS

EPS

-$0.82
SRDX annual earnings per share is -$0.82

EPS Analysts estimate

-$0.26
SRDX annual earnings per share is currently +219.44% higher than the consensus analysts' forecast

EPS 1-year change

-645.45%
SRDX annual earnings per share is down -645.45% year-on-year

EPS Sector rank

60.43%
SRDX annual earnings per share is higher than 60.43% of companies in Healthcare sector

Profit

Gross profit

$54.69M
SRDX annual gross profit is $54.69 million

Gross margin

43.38%
SRDX annual gross profit margin is 43.38%

Operating profit

-$5.64M
SRDX annual operating income is -$5.64 million

Operating margin

-4.48%
SRDX annual operating profit margin is -4.48%

Net income

-$11.54M
SRDX annual net profit is -$11.54 million

Net margin

-9.15%
SRDX annual net profit margin is -9.15%

Expenses

Total expenses

$131.72M
SRDX annual total expenses is $131.72 million

Operating expenses

$60.34M
SRDX annual total operating expenses is $60.34 million

Cost of goods sold

$71.39M
SRDX annual cost of goods sold is $71.39 million

Selling, general & administrative expenses

$56.84M
SRDX annual SGA is $56.84 million

Depreciation and amortization

$8.69M
SRDX annual depreciation & amortization is $8.69 million

Interest expense

$3.54M
SRDX annual interest expense is $3.54 million

Income tax

$4.04M
SRDX annual income tax is $4.04 million

EBIT & EBITDA

EBIT

-$5.64M
SRDX annual earnings before interest & taxes is -$5.64 million

EBITDA

$3.05M
SRDX annual EBITDA is $3.05 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$178.56M
SRDX annual total assets is $178.56 million

Non current assets

$97.26M
SRDX annual long term assets is $97.26 million

Current assets

$81.30M
SRDX annual total current assets is $81.30 million

Cash and cash equivalents

$36.12M
SRDX annual cash & cash equivalents is $36.12 million

Accounts receivable

$13.29M
SRDX annual accounts receivable is $13.29 million

Inventory

$15.17M
SRDX annual inventory is $15.17 million

Liabilities

Total liabilities

$59.66M
SRDX annual total liabilities is $59.66 million

Long term liabilities

$39.12M
SRDX annual total long term liabilities is $39.12 million

Current liabilities

$20.54M
SRDX annual total current liabilities is $20.54 million

Accounts payable

$2.79M
SRDX annual accounts payable is $2.79 million

Debt

Total debt

$33.24M
SRDX annual total debt is $33.24 million

Total debt 1-year change

-0.03%
SRDX annual total debt is down -0.03% year-on-year

Long term debt

$32.20M
SRDX annual long term debt is $32.20 million

Short term debt

$1.04M
SRDX annual short term debt is $1.04 million

Equity & Capital

Shareholders equity

$118.90M
SRDX annual stockholders equity is $118.90 million

Book value

$118.90M
SRDX annual book value is $118.90 million

Retained earnings

$75.71M
SRDX annual retained earnings is $75.71 million

Working capital

$60.76M
SRDX annual working capital is $60.76 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$248.00K
SRDX annual cash flow from operations is $248.00 thousand

Cash from operations 1-year change

-97.64%
SRDX annual cash flow from operations is down -97.64% year-on-year

Cash from investing

-$2.94M
SRDX annual cash flow from investing activities is -$2.94 million

Cash from investing 1-year change

+56.95%
SRDX annual cash flow from investing activities is up +56.95% year-on-year

Cash from financing

-$2.95M
SRDX annual cash flow from financing activities is -$2.95 million

Cash from financing 1-year change

-116.03%
SRDX annual cash flow from financing activities is down -116.03% year-on-year

CAPEX

CAPEX

$3.49M
SRDX annual capital expenditures is $3.49 million

CAPEX 1-year change

+19.67%
SRDX annual capital expenditures is up +19.67% year-on-year

Free Cash Flow

Free cash flow

-$3.24M
SRDX annual free cash flow is -$3.24 million

Free cash flow 1-year change

-142.71%
SRDX annual free cash flow is down -142.71% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

43.38%
SRDX annual gross profit margin is 43.38%

Operating margin

-4.48%
SRDX annual operating profit margin is -4.48%

Net margin

-9.15%
SRDX annual net profit margin is -9.15%

ROA & ROE

ROA

-6.34%
SRDX annual return on assets is -6.34%

ROE

-9.67%
SRDX annual return on equity is -9.67%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
SRDX price to earnings ratio value is unknown

PE ratio Sector rank

-
SRDX price to earnings ratio is unknown

PB Ratio

PB ratio

3.77
SRDX price to book ratio is 3.77

PB ratio Sector rank

76.83%
SRDX price to book ratio is higher than 76.83% of companies in Healthcare sector

PS Ratio

PS ratio

3.36
SRDX price to sales ratio is 3.36

PS ratio Sector rank

53.77%
SRDX price to sales ratio is higher than 53.77% of companies in Healthcare sector

Enterprise value

Enterprise value

$424.04M
SRDX enterprise value is $424.04 million

Enterprise value Sector rank

66.47%
SRDX enterprise value is higher than 66.47% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

188.97
SRDX EV/EBITDA is 188.97

EV/EBITDA Sector rank

99.38%
SRDX EV/EBITDA is higher than 99.38% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

3.96
SRDX annual current ratio is 3.96

Quick ratio

3.22
SRDX annual quick ratio is 3.22

Leverage

Debt to equity

0.25
SRDX annual debt to equity ratio is 0.25

Interest coverage ratio

-1.59
SRDX annual interest coverage ratio is -1.59

Risk & Stability

Piotroski F-Score

5
SRDX piotroski f-score is 5

Altman Z-Score

5.84
SRDX altman z-score is 5.84

Analyst ratings

Recent major analysts updates

Mar 7, 25 Lake Street
Buy
Jan 30, 25 Needham
Hold
Nov 7, 24 Needham
Hold
Aug 5, 24 Needham
Hold
May 30, 24 Barrington Research
Market Perform
May 29, 24 Sidoti & Co.
Neutral
May 29, 24 Needham
Hold
May 29, 24 Lake Street
Hold
May 2, 24 Barrington Research
Outperform
May 1, 24 Needham
Buy

Institutional Ownership

Similar stocks

SNDA logo
Sonida Senior Living (SNDA)
TMCI logo
Treace Medical Concepts (TMCI)
Beta Bionics (BBNX)
ETON logo
Eton Pharmaceuticals (ETON)
OMER logo
Omeros (OMER)
INNV logo
InnovAge Holding (INNV)
PRTC logo
PureTech Health (PRTC)
CELC logo
Celcuity (CELC)
ABVX logo
ABIVAX SA (ABVX)
  • What is the ticker symbol for Surmodics?
  • Does Surmodics pay dividends?
  • What sector is Surmodics in?
  • What industry is Surmodics in?
  • What country is Surmodics based in?
  • When did Surmodics go public?
  • Is Surmodics in the S&P 500?
  • Is Surmodics in the NASDAQ 100?
  • Is Surmodics in the Dow Jones?
  • When was Surmodics's last earnings report?
  • When does Surmodics report earnings?
  • Should I buy Surmodics stock now?

What is the ticker symbol for Surmodics?

The ticker symbol for Surmodics is NASDAQ:SRDX

Does Surmodics pay dividends?

No, Surmodics does not pay dividends

What sector is Surmodics in?

Surmodics is in the Healthcare sector

What industry is Surmodics in?

Surmodics is in the Medical Devices industry

What country is Surmodics based in?

Surmodics is headquartered in United States

When did Surmodics go public?

Surmodics's initial public offering (IPO) was on March 4, 1998

Is Surmodics in the S&P 500?

No, Surmodics is not included in the S&P 500 index

Is Surmodics in the NASDAQ 100?

No, Surmodics is not included in the NASDAQ 100 index

Is Surmodics in the Dow Jones?

No, Surmodics is not included in the Dow Jones index

When was Surmodics's last earnings report?

Surmodics's most recent earnings report was on Jan 30, 2025

When does Surmodics report earnings?

The next expected earnings date for Surmodics is May 1, 2025

Should I buy Surmodics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page